Search results
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 2 days agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...
Pharma giant's data breach exposes patients' sensitive information
Fox News via Yahoo News· 4 days agoPharmaceutical giant Cencora has notified people that private medical information, including health...
Critical Mass With Law.com’s Amanda Bronstad: Boeing CEO Gets Grilled Over Safety Lapses, Talc...
Law.com· 1 day agoThe same plaintiffs’ firms that sued last month to stop Johnson & Johnson’s planned third bankruptcy...
AstraZeneca/Fibrogen’s Roxadustat FDA Review Further Delayed Following Unanticipated Advisory...
Clinical Trials Arena via Yahoo Finance· 4 days agoFDA Delays Decision on AstraZeneca/Fibrogen’s Roxadustat for CKD Anemia On March 1, AstraZeneca and...
Harte Hanks Launches Demand Generation In a Box
Digital Journal· 2 days agoTurnkey Suite of Services Give Small and Medium Businesses the Data, People, and Content Needed to Drive Interest in their Brand CHELMSFORD, MA / ACCESSWIRE / June 19, 2024 / Harte Hanks, Inc. (NASDAQ:HHS), the 101-year-old Massachusetts-based global
$35 inhaler price cap expected to save lives in Pa.
WFMZ Eastern Pennsylvania and Western New Jersey· 2 days agoBreathing in the hot air can be a problem for people with asthma, but something that should have asthma patients breathing a little easier: major inhaler...
Baird lifts Mirum Pharmaceuticals shares target on study results By Investing.com
Investing.com· 4 days agoOn Monday, Baird increased its price target on Mirum Pharmaceuticals (NASDAQ:MIRM) shares to $39...
Citi holds Buy rating on Mirum stock on positive trial updates By Investing.com
Investing.com· 4 days agoOn Monday, Citi maintained a Buy rating on Mirum Pharmaceuticals (NASDAQ:MIRM) with a steady price...
Gateway - Quartz
Quartz· 3 days agoThe research was led by scientists from the University of Surrey and involved others from the University of College London and the pharmaceutical company GSK (formerly known as GlaxoSmithKline ...
Gateway - Quartz
Quartz· 2 days ago23andMe is in a death spiral. Almost everyone who wants a DNA test already bought one, a nightmare data breach ruined the company’s reputation, and 23andMe’s stock is so close to worthless it ...
